Status:
UNKNOWN
Trans Caesarean Intra Uterine Contraceptive Device Insertion Versus Conventional Postpartum 6 Weeks Insertion
Lead Sponsor:
Al-Azhar University
Conditions:
IUD
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
To compare immediate post-placental intrauterine contraceptive device insertion versus conventional placement at 6 weeks interval (often referred to as delayed or interval insertion) as regard to:- 1...
Detailed Description
Until the 1960s, Intrauterine devices (IUCDs) and condoms were the only artificial methods for the control of fertility. Nowadays ,despite the presence of 12 contraceptive methods which include 9 mode...
Eligibility Criteria
Inclusion
- Age: 18-40years.
- Full term pregnancies delivered by cesarean section.
- Desire to have intrauterine contraceptive device (Cu T) as a contraceptive option.
- Agree to participate in the study.
Exclusion
- Allergy to copper.
- Ante- or intra-partum hemorrhage.
- Ruptured of membranes for more than 18 h prior to delivery or Chorioamnionitis.
- Known uterine abnormalities e.g., Bicornuate/septate Uterus, uterine myoma.
- History of ectopic pregnancy.
- Desire for pregnancy within 1 year of delivery.
- Intrapartum fever \>38 c.
- Sever thrombocytopenia.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06023849
Start Date
September 1 2023
End Date
September 1 2024
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicin
Asyut, Egypt